Video
4 Sep 2024
InnoGI Technologies Demonstration: Simulating the real human gastrointestinal tract
JPG 5.3 MB
Discover how the SurroGUT™ platform, mimicking with high fidelity the human GI tract, offers valuable visibility and insights into both pharmaceutical drug development and food research projects. Whether you're looking to accelerate your pharmaceutical pipeline or innovate within the food industry, SurroGUT™ equips you with the tools to significantly reduce risks and achieve a faster time to market.
Content provided by our supplier
InnoGI Technologies.
-
NL -
2024On CPHI since
-
25 - 49Employees
Company types
Primary activities
Other Content from InnoGI Technologies. (1)
-
News InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance
InnoGI Technologies (formerly The TIM Company) is pleased to announce an exciting, market-driven collaboration with Simulations Plus to combine its TIM Technology, part of the InnoGI SurroGUT™ platform, with the GastroPlus® and ADMET Predictor® modelling software offered by Simulations Plus.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance